Sign Up to like & get
recommendations!
1
Published in 2023 at "Nordic journal of psychiatry"
DOI: 10.1080/08039488.2022.2160878
Abstract: BACKGROUND Clozapine is the gold standard for treating treatment-resistant schizophrenia (TRS) although widely underutilised. Both organisational, patient- and clinician related reasons for the underutilisation have been reported, however, the clinical impact of either in real-world…
read more here.
Keywords:
audit;
clozapine treatment;
reasons non;
non clozapine ... See more keywords